Baxter International on Thursday recalled one shipment of Intralipid due to temperature control issues.
Here are four things to know.
1. Intralipid is a fat emulsion product that supplies calories to patients who are fed intravenously.
2. The shipment was accidentally exposed to subfreezing temperatures while in transit to a distribution center. When frozen, Intralipid can expand and form aggregates that can block pulmonary circulation.
3. Baxter has not received any reports of adverse events associated with the Intralipid shipment.
4. The company is informing customers of the recall and arranging for the return and refund of affected products.
More articles on supply chain:
Jury orders AbbVie to pay $140M+ for misrepresenting testosterone drug risks
J&J exits insulin pump business: 4 things to know
CVS rolls out medication management tool: 4 things to know